Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03132337 · ClinicalTrials.gov registry record
Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 80
- Enrollment target
NCT03132337: Completed study, sponsored by Indiana University.
NCT03132337 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03132337 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The goal of this is to learn more about stem cell transplant and complications that some people have after their transplants, in particular sinusoidal obstruction syndrome (SOS), also called veno-occlusive disease of the liver.
Primary Outcome
Measure for 3 SOS proteomic markers, L-Ficolin, HA, and ST2, as early predictors of SOS incidence through study completion.
Interventions
- OTHER Serial Blood Draws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2021-01-14 |
What the finished NCT03132337 record still lists
NCT03132337 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Serial Blood Draws is the first listed.
NCT03132337 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03132337 about?
NCT03132337 is a clinical study titled "Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study". The goal of this is to learn more about stem cell transplant and complications that some people have after their transplants, in particular sinusoidal obstruction syndrome (SOS), also called veno-occlusive disease of the liver.
What is the current status of trial NCT03132337?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2017-04-01. Estimated completion is 2021-01-14.
What interventions are being tested in trial NCT03132337?
The interventions under investigation include: Serial Blood Draws (OTHER).
Who is sponsoring clinical trial NCT03132337?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI